The Economist · June 12, 2026
At a conference in Chicago, oncologists celebrated the breakthrough drug daraxonrasib, which doubled pancreatic cancer survival times. The drug targets the K-R-A-S protein, potentially opening up treatments for other can…
The Economist · 2026-06-14
As AI agents and token-heavy reasoning models drive up business expenses, companies are abandoning the culture of unrestricted usage known as 'tokenmaxxing.' To control skyrocketing bills, organizations are turning to ch…
The Economist · June 11, 2026
Unprecedented numbers of millionaires are migrating globally due to geopolitical and political anxieties, driving a massive boom in the investment-migration industry, even as some destination countries begin to tighten t…
The Economist · May 6th 2026
An anonymous former Russian government official argues that Vladimir Putin is losing his hold on the country, as the war in Ukraine drains national resources, elites grow anxious over arbitrary property seizures, Russia'…
The New York Times · June 8, 2026
As tens of millions of people use GLP-1 weight-loss drugs like Ozempic, researchers are gaining a clearer real-world understanding of their impacts. Beyond treating obesity and diabetes, these medications show promise in…